Rangers agree to a deal with Kyuji Fujikawa

5 Comments

T.R. Sullivan of MLB.com reports that the Rangers have signed reliever Kyuji Fujikawa, pending a physical. Exact terms aren’t yet known, but Jeff Wilson of the Fort Worth Star-Telegram hears that he’ll get a one-year contract with an option for 2016.

Fujikawa was expected to handle the closer role when the Cubs brought him over from Japan for $9.5 million two years ago, but he struggled in 12 appearances in 2013 before undergoing Tommy John surgery. The 34-year-old right-hander made it back to the majors this past August and posted a 4.85 ERA with 17 strikeouts and six walks over 16 innings down the stretch. He hit free agency after the Cubs declined a $5.5 million option on him in October.

It’s a low-risk move which could pay off nicely if Fujikawa is healthy and gets a better feel for his command the further removed he becomes from surgery.

Mets, Jacob deGrom agree to a five-year, $137.5 million contract extension

Getty Images
3 Comments

The Mets have a deal on a contract extension with ace Jacob deGrom. Andy Martino of SNY was the first to report the deal. The terms, per Ken Rosenthal: five years, $137.5 million with a club option for 2024. deGrom gets a full no-trade clause and has a potential opt-out after 2022.

Sale was slated to earn $17 million this year, so the deal contains $120.5 million in new money. There will be some restructuring, however: he’ll still get $17 million this year, but $10 million of it is as as signing bonus and $7 million of it is in salary. He’ll get $23 million in 2020, $33.5 million in 2021 and 2022 and, if he doesn’t opt-out, $30.5 million in 2023 and $32.5 million as the club option in 2024. The overall average annual value of the deal — which covers this year and next year, which would’ve been arbitration, and three potential years of free agency, is $27.5 million

Overall, the contract is very similar to the one Chris Sale just signed, even though he is a year further from free agency. deGrom will earn $107 million between now and his opt-out date. Sale will earn $105 million. Of course, if the doesn’t opt-out the deal runs through 2023, with that club option for 2024.

deGrom, the 2018 Cy Young Award winner has made no secret of his desire for a contract extension. He, likewise, has said he would not discuss the matter with the Mets after the start of the season on Thursday. This, then, is getting the job done, just under the wire.

deGrom is coming off of a season in which he posted a 1.70 ERA with 269 strikeouts and 46 walks across 217 innings. It’s the lowest ERA by a qualified starter since Zack Greinke‘s 1.66 in 2015. Prior to Greinke, no pitcher had posted an ERA of 1.70 or lower since Greg Maddux in 1994-95 (1.56, 1.63).

deGrom will turn 31 years old in June. He’ll be 35 when the deal ends or, if the option is picked up, 36.